Counterfeit GLP-1s and Online Pharmacy Checks: What You Can Verify Before Paying

A polished website and a low advertised price are easy to compare. The dispensing pharmacy and the product's supply chain require a different kind of check. Neither a consumer review score nor a photograph of a pen can establish that a medicine is authentic, appropriately prescribed or suitable for you.

This guide covers checks a shopper can make and the limits of those checks. It does not authenticate a product, inspect a pharmacy or certify a provider's clinical quality.

Identify three different businesses

A GLP-1 purchase can involve a website or technology company, a medical group that employs or contracts with the prescriber, and a pharmacy that dispenses the medicine. A familiar storefront name does not necessarily identify the other two. Ask who performs each role and keep the names and contact information.

Before paying, ask which pharmacy is expected to fill the prescription and when you will be told if that changes. “A network of licensed pharmacies” gives less information than an identifiable dispensing location. A company's refusal to name a pharmacy should prompt further questions rather than a guess based on a logo.

Our provider-selection checklist covers the broader commercial comparison, including charges and cancellation. Pharmacy verification is one part of it, not a substitute for checking the rest of the plan.

Use the state board, not only a seal

FDA's BeSafeRx resources describe signs of safer online pharmacies: requiring a prescription, having a U.S. address and phone number, a licensed pharmacist available to answer questions and appropriate state licensing¹. Use the relevant state board's official lookup to check the entity and address. Ask the pharmacy if you cannot resolve a name or location mismatch.

A certification seal can be a useful lead, but it should resolve to the certifier's actual record for that business. An image that merely resembles a seal establishes little. A license check likewise does not guarantee that every batch is sterile or that every advertised drug is approved; understand what the record actually confirms.

For a compounded product, ask for the exact pharmacy and address rather than assuming all locations with the same brand have the same regulatory history. A record about one facility should not be treated as a finding about a different address without evidence.

Counterfeit is different from compounded

FDA has warned about counterfeit Ozempic in the U.S. supply chain². Counterfeit products can misrepresent identity or origin. A compounded medication is a different category: it is prepared for a clinical need through a compounding pathway and is not an FDA-approved finished drug. Calling a compound “generic Ozempic” obscures that distinction.

FDA also warns about unapproved GLP-1 products sold illegally and products labeled for research rather than human use³. A research label is not a prescription pathway. Do not assume a product becomes an appropriate medicine because a seller supplies a dosing chart or a third-party laboratory document.

The compounded-versus-brand guide explains the cost comparison. Lower cost does not remove the need to understand which type of product you are considering.

Can the package prove authenticity?

Do not rely on a photo match to authenticate a pen, carton or vial. Packaging can be copied and legitimate presentations can change. If you suspect a product is counterfeit or otherwise unsuitable, contact the dispensing pharmacist and prescriber before using it. Keep the packaging, label, receipt and order details so they can identify the exact product.

FDA's counterfeit alerts identify specific events and products. They are not a complete visual checklist for all counterfeits and do not show that an unlisted product is genuine². Check the current alert rather than circulating an old lot-number screenshot as a universal rule.

If you feel acutely unwell after using a suspect medicine, seek medical attention promptly and tell the treating team what was taken. Reporting a concern is separate from receiving care.

How should price affect the decision?

An unusually low price deserves scrutiny, but price alone cannot diagnose a counterfeit. A high price cannot authenticate one either. First establish what is being sold, who prescribes it, who dispenses it and what the written supply instructions say. Then compare the payment term.

For example, a hypothetical “$99 monthly” offer might require $594 for six months upfront. That is a billing fact, not evidence of product quality. A “membership included” statement also does not tell you which pharmacy fills the prescription. Keep the authenticity questions and the total-cost calculation visible together.

A short prepayment record

Save the business and pharmacy names, the expected product and formulation, what the payment covers and the refund policy. Ask how replacement is handled if a shipment arrives unsuitable, and where clinical questions go. Do not enter health details into unrelated verification services merely because they appear in a search result.

For compounded vials, get the concentration and written dating instructions. Our beyond-use and after-puncture guide explains why advertised months of supply are not enough. If a seller cannot answer basic identity and dispensing questions before collecting a large payment, pause the purchase and seek clarification from an identifiable licensed professional.